LATAMBif Registry: February 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. 

The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. 

Bellow you will find data from February 2021, which includes all patients enrolled by the different Latin American centers taking part in the register. 

February data

So far, the registry has included 157 patients of mean age 65.65 (+- 11.35): 86,1% men, and 13,9% women.

Among the risk factors, we have found 82,4% had a history of hypertension, 76,9% dyslipidemia, 12,8% were smokers, 17,6% had type 2 diabetes and 1,6% had type 1 diabetes. In addition, 42,8% had prior PCI, 5,9% prior CABG and 27,3% prior MI.

Of all included patients, 37,4% presented chromic coronary syndrome, 26,7% unstable angina, 17,1% Non-ST acute myocardial infarction (NSTEMI), 11,2% were asymptomatic (silent ischemia) 7,5% ST elevation MI (STEMI).

As regards clinical indications, 55,1% received elective indication, 35,8% urgent indication and 9,1% emergency indication.

83,3% of vascular access was transradial (proximal), 3,2% transradial (distal) and12, 13,4% femoral.

As to the initial strategy, 73,3% was the provisional stent technique and 26,7% the two stent technique.

Monthly-report-february-2021

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...